Clinical and analytical validation of FoundationOne(®)CDx, a comprehensive genomic profiling assay for solid tumors

FoundationOne(®)CDx (F1CDx) is a United States (US) Food and Drug Administration (FDA)-approved companion diagnostic test to identify patients who may benefit from treatment in accordance with the approved therapeutic product labeling for 28 drug therapies. F1CDx utilizes next-generation sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Milbury, Coren A., Creeden, James, Yip, Wai-Ki, Smith, David L., Pattani, Varun, Maxwell, Kristi, Sawchyn, Bethany, Gjoerup, Ole, Meng, Wei, Skoletsky, Joel, Concepcion, Alvin D., Tang, Yanhua, Bai, Xiaobo, Dewal, Ninad, Ma, Pei, Bailey, Shannon T., Thornton, James, Pavlick, Dean C., Frampton, Garrett M., Lieber, Daniel, White, Jared, Burns, Christine, Vietz, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926248/
https://www.ncbi.nlm.nih.gov/pubmed/35294956
http://dx.doi.org/10.1371/journal.pone.0264138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926248/
https://www.ncbi.nlm.nih.gov/pubmed/35294956
http://dx.doi.org/10.1371/journal.pone.0264138

Ejemplares similares